Related references
Note: Only part of the references are listed.Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data
Valeria Dipasquale et al.
EXPERT OPINION ON DRUG SAFETY (2022)
Dermatologic adverse reactions to proton-pump inhibitors: A synthetized review
Antoine Salloum et al.
JOURNAL OF COSMETIC DERMATOLOGY (2021)
The effects of proton pump inhibitors on the microbiome in young children
Elvira Levy et al.
ACTA PAEDIATRICA (2020)
Addressing long-term PPI safety
Carmelo Scarpignato et al.
DIGESTIVE AND LIVER DISEASE (2020)
Latest insights into the hot question of proton pump inhibitor safety - a narrative review
Vincenzo Savarino et al.
DIGESTIVE AND LIVER DISEASE (2020)
Adverse Events of Proton Pump Inhibitors: Potential Mechanisms
Andrea Corsonello et al.
CURRENT DRUG METABOLISM (2018)
Potential Effects of Bariatric Surgery and Reduced Interleukin 32 Levels on Type 2 Diabetes and Its Comorbidities Reply
Edward Mitre et al.
JAMA PEDIATRICS (2018)
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database
Alice Capogrosso Sansone et al.
DRUG SAFETY (2017)
National trends in prescription drug expenditures and projections for 2016
Glen T. Schumock et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression
Carmelo Scarpignato et al.
BMC MEDICINE (2016)
Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews
Jason Abramowitz et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2016)
Understanding adverse drug reactions in older adults through drug-drug interactions
A. Marengoni et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Evaluation and management of hypersensitivity to proton pump inhibitors
Sumit Bose et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence
David A. Johnson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Efficacy and Safety of Once-Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease in Neonatal Patients
Geoffrey Davidson et al.
JOURNAL OF PEDIATRICS (2013)
Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD The LOTUS Randomized Clinical Trial
Jean-Paul Galmiche et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis
Lars Lundell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease
S Fiedorek et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children
V Tolia et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
HMG-CoA reductase inhibitors and P-glycoprotein modulation
K Bogman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies
RM Martin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
